WO2023152671 - PHARMACEUTICAL COMPOSITIONS COMPRISING A 225-ACTINIUM-LABELLED COMPLEX AND A BISMUTH SEQUESTERING AGENT
National phase entry:
Publication Number
WO/2023/152671
Publication Date
17.08.2023
International Application No.
PCT/IB2023/051159
International Filing Date
09.02.2023
Title **
[English]
PHARMACEUTICAL COMPOSITIONS COMPRISING A 225-ACTINIUM-LABELLED COMPLEX AND A BISMUTH SEQUESTERING AGENT
[French]
COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN COMPLEXE MARQUÉ PAR 225-ACTINIUM ET UN AGENT SÉQUESTRANT LE BISMUTH
Applicants **
NOVARTIS AG
Lichtstrasse 35
4056 Basel, CH
Inventors
CASTALDI, Elena
c/o Advanced Accelerator Applications (Italy) - S.R.L., Via dell'Industria Prima Traversa
86077 Pozilli, IT
ZAHI, Ilyes
20 Rue Diesel
01630 Saint-Genis-Poulilly, FR
FORMENTO CAVAIER, Roberto
c/o Advanced Accelerator Applications (Italy) - S.R.L., Via dell'Industria Prima Traversa
086077 Pozzilli, IT
MAINERO, Valentina
c/o Advanced Accelerator Applications (Italy) - S.R.L, Via dell'industria Prima Traversa
86077 Pozzilli, IT
MARIANI, Maurizio F
c/o Advanced Accelerator Applications (Italy) - S.R.L.
Via dell'industria Prima Traversa
86077 Pozzilli (Isernia), IT
Priority Data
63/308,211
09.02.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| Sequence Listing | * |
| International Search Report is established | *
International Searching Authority
EPO
* |
| Applicant's Legal Status |
Legal Entity
* * * * * |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1367 | |
| EPO | Filing, Examination | 7003 | |
| Japan | Filing | 557 | |
| South Korea | Filing | 577 | |
| USA | Filing, Examination | 2835 |
Total: 12339 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
. The disclosure also concerns a method for preparing said pharmaceutical composition.[French]
. L'invention concerne également un procédé de préparation de ladite composition pharmaceutique.